『Gastrointestinal motility activator
‘Easyton Jeong’ Release』
KyungDong Pharm Co., Ltd. released ‘Easytone Tablets (Itopride Hydrochloride 50mg)’, a medicine for the digestive system, on January 28th. ‘Easyton Tablet’ is a medicine administered for the purpose of improving symptoms caused by functional dyspepsia and is classified as a ‘gastrointestinal motility activator’.
Among gastrointestinal motility activators, the most marketed ones are drugs that block the Dopamine D2 receptor. However, in the case of these Dopamine D2 receptor blockers, they cause galactorrhea, gynecomastia, or extrapyramidal side effects due to increased prolactin secretion due to central Dopamine D2 receptor blocking, whereas ‘Easytone Tablets’ selectively act on peripheral Dopamine D2 receptors, so the occurrence of such side effects is very low. Domperidone is classified as a peripheral Dopamine D2 receptor blocker along with Itopride, the defining ingredient of Easytone. Compared to Domperidone, the above side effects are significantly less common.
In addition, while existing agents only act to promote the secretion of ‘acetylcholine’, a substance that promotes gastrointestinal motility, from the end of gastric smooth muscle, Easytone tablets even inhibit the decomposition of acetylcholine by inhibiting the action of ‘Acetylcholine Esterase’, which decomposes ‘acetylcholine’. Therefore, it maintains a relatively higher concentration of acetylcholine than existing preparations, showing an equal or better effect.
Another characteristic of Easyton's definition lies in the differentiation of metabolic processes. While Mosapride and Domperidone are metabolized in the liver through CYP450, Easytone tablets are metabolized by Flavin Mono Oxygenase (FMO), so their activity is not reduced even when co-administered with drugs metabolized by CYP450 such as Cimetidine, Itraconazole, and Chlarythromycin.
As such, ‘Easytone Tablet’, which has characteristics that clearly differentiate it from existing gastrointestinal motility agents, is expected to grow into a very powerful flagship product, following other digestive tract drugs such as Rebamipide and Nizatidine released by KyungDong Pharm Co., Ltd.
◁ Product information ▷
◈ Product name: Easyton tablet
◈ Ingredient content: Itopride HCl 50mg
◈ Efficacy: Improvement of digestive symptoms caused by functional dyspepsia
◈ Dosage: Adults, take 1 tablet 3 times a day before meals.
◈ Insurance claim code: 648100170
◈ Packaging unit: 30 tablets, 300 tablets
◈ Standard drug price: 144 won/tablet
※ Please refer to the product manual for further details, including precautions for use.